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Spinal Infections: From Prevention to Cure
Presentation and Outcomes After Medical
and Surgical Treatment Versus Medical
Treatment Alone of Spontaneous Infectious
Spondylodiscitis: A Systematic Literature
Review and Meta-Analysis
Davis G. Taylor, MD1, Avery L. Buchholz, MD2, Durga R. Sure, MD3,
Thomas J. Buell, MD1, James H. Nguyen, MD1, Ching-Jen Chen, MD1,
Joshua M. Diamond1, Perry A. Washburn4, James Harrop, MD5,
Christopher I. Shaffrey, MD1, and Justin S. Smith, MD, PhD1
Abstract
Study Design: Systematic literature review.
Objectives: The aims of this study were to (1) describe the clinical features, disabilities, and incidence of neurologic deficits of
pyogenic spondylodiscitis prior to treatment and (2) compare the functional outcomes between patients who underwent medical
treatment alone or in combination with surgery for pyogenic spondylodiscitis.
Methods: A systematic literature review was performed using PubMed according to PRISMA guidelines. No year restriction was
put in place. Statistical analysis of pooled data, when documented in the original report (ie, number of patients with desired
variable and number of patients evaluated), was conducted to determine the most common presenting symptoms, incidence of
pre- and postoperative neurologic deficits, associated comorbidities, infectious pathogens, approach for surgery when performed,
and duration of hospitalization. Outcomes data, including return to work status, resolution of back pain, and functional recovery
were also pooled among all studies and surgery-specific studies alone. Meta-analysis of studies with subgroup analysis of pain-free
outcome in surgical and medical patients was performed.
Results: Fifty of 1286 studies were included, comprising 4173 patients undergoing either medical treatment alone or in com-
bination with surgery. Back pain was the most common presenting symptom, reported in 91% of patients. Neurologic deficit was
noted in 31% of patients. Staphylococcus aureus was the most commonly reported pathogen, seen in 35% of reported cases.
Decompression and fusion was the most commonly reported surgical procedure, performed in 80% of the surgically treated
patients. Combined anterior-posterior procedures and staged surgeries were performed in 33% and 26% of surgeries, respec-
tively. The meta-analysis comparing visual analog scale score at follow-up was superior among patients receiving surgery over
medical treatment alone (mean difference 0.61, CI 0.90 to 0.25), while meta-analysis comparing freedom from pain in
patients receiving medical treatment alone versus combined medical and surgical treatment demonstrated superior pain-free
outcomes among surgical series (odds ratio 5.35, CI 2.27-12.60, P < .001), but was subject to heterogeneity among studies
(I2 ¼ 56%, P ¼ .13). Among all patients, freedom from pain was achieved in 79% of patients, and an excellent outcome was
achieved in 73% of patients.
Conclusion: Medical management remains first-line treatment of infectious pyogenic spondylodiscitis. Surgery may be indicated
for progressive pain, persistent infection on imaging, deformity or neurologic deficits. If surgery is required, reported literature
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shows potential for significant pain reduction, improved neurologic function and a high number of patients returning to a normal
functional/work status.
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Introduction
Spondylodiscitis is an infectious disease of the intervertebral
disc space and adjacent vertebral end plates.1 Most patients
with discitis present initially with back pain and often have
significant delays in time to diagnosis.2 Severity of back pain
can be quite significant, resulting in poor quality of life and
disability scores.3 Continued bone and disc destruction from
prolonged, chronic infection may progress to significant spinal
deformity in a subset of patients, with resultant worsening
quality of life.4 The goals of this study were first to describe
the clinical features, disabilities and neurologic deficits of pyo-
genic spondylodiscitis on presentation, and second to compare
the functional outcomes between patients who underwent med-
ical and surgical management for pyogenic spondylodiscitis.
Methods
Inclusion and Exclusion Criteria
In an effort to maximize inclusion of relevant literature regard-
ing medical and surgical management of primary pyogenic
spondylodiscitis, the following inclusion criteria were used:
(1) study must contain at least 10 patients, (2) the primary focus
of the study must be surgical or medical management with
reported outcome of spontaneous discitis, (3) article must be
written in English, (4) the study must involve human subjects,
and (5) the articles must be found in MEDLINE journal cate-
gories. Case reports, reviews, technical notes, or studies involv-
ing primarily pediatric patients (age <18 years), vertebral
abscess, iatrogenic discitis, or those focusing on one specific
pathogen were excluded. If multiple studies were published by
a single author, only the largest series was included.
Literature Search
For the present systematic review, a focused search on PubMed
was considered sufficient. A systematic review was performed
on March 21, 2018 using PubMed with the following search
term: (“discitis” OR “spondylodiscitis” OR “diskitis”) and
(“management” OR “treatment” OR “surgery” OR “surgical”).
Results were restricted to Medline journal categories regarding
human subjects and published in English, of which 1286 arti-
cles resulted. Article titles were evaluated to identify those
related to the medical or surgical management and outcomes
of discitis or vertebral osteomyelitis. Studies not meeting the
aforementioned inclusion criteria were excluded (Figure 1). A
total of 111 abstracts were reviewed and application of inclu-
sion criteria was repeated, which excluded an additional 55
studies. For the remaining 56 studies, we reviewed the full-
text journal articles, and 48 achieved criteria for inclusion.
Following, a search was performed on Cochrane Review for
additional articles using the same inclusion and exclusion cri-
teria, identifying 2 additional articles. Finally, 50 full-text jour-
nal articles were available for evaluation.
Literature Review and Data Extraction
A protocol was registered with PROSPERO for this review
(CRD42018092268), and the review follows the guidelines
established by the Preferred Reporting Items for Systematic
Reviews and Meta-Analyses (PRISMA).5 When provided by
the original article, demographic, clinical, pathological, sur-
gical, and outcome data was extracted from selected studies.
Demographic data included the number of patients, sex, age,
and associated comorbidities. Clinical data included time to
diagnosis, imaging modality, presenting symptoms, relevant
laboratory values, culture source, and results. Outcome data
included duration at follow-up, pain at follow-up, presence
of neurologic deficits, and return to work. A composite
score of excellent functional outcomes was created to
capture the various reports of return to work with normal
activity, freedom from pain at last follow-up, Oswestry Dis-
ability Index (ODI) score less than 20, or a Kirkaldy-Willis
Score of 3 or greater. Surgery-specific series were further
evaluated to determine type of surgery (decompression
alone, decompression and fusion, combined anterior-
posterior approach, or staged surgery).
Statistical Analysis
Pooled data were gathered from all available articles and con-
tinuous variables were summarized with means calculated
based on the numbers of patients pooled from each article.
When available, comparison of pain outcomes after medical
and surgical treatment versus medical treatment alone was
performed using Review Manager (RevMan), version 5.3
(Copenhagen: The Nordic Cochrane Centre, the Cochrane Col-
laboration, 2012). Odds ratios for individual studies and the
sum of studies were computed using the Mantel-Haenszel test.
Mean difference was determined using RevMan as well. Study
heterogeneity was detected using the chi-square and I2 test
statistics. Given the limitations on the power of the chi-
square test by the small number of studies in the analyses,
significant heterogeneity was considered to be present when
both the chi-square value was within 10% level of significance
(P < .10) or the I2 value exceeded 50%.
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Results
Study Selection
The search term resulted in 1286 articles for review. Among
these, 111 articles were selected for further review of abstracts
based on title and relevance to inclusion and exclusion criteria.
Application of inclusion and exclusion criteria to study
abstracts yielded 56 articles. The full-text articles for these
56 studies were then reviewed and subjected to our inclusion
criteria, after which 48 articles were eligible for systematic
review.3,6-52 (Figure 1) Following an additional search on
Cochrane Review, 2 additional studies53,54 were found, and a
total of 50 articles were eligible for final systematic review
(Tables 1 and 2) 16 studies reported both surgical and medical
outcomes. All but 3 studies were retrospective in nature.
Demographic and Presenting Clinical Data
Demographic and clinical data for the 4173 patients from the 50
studies included in this systematic review are summarized in
Table 3. The mean patient age at presentation was 58.3 years,
and 60% of the patients were men. The mean time to diagnosis
from initial symptom onset was 54.93 days. Back pain was the
most commonly reported presenting symptom, occurring in 91%
(2101/2299) of patients. Other commonly observed findings
included fever (35%, 748/2125) and focal neurologic deficits
(29%, 1009/3422. Among the patients treated surgically, back
pain (88%, 674/770) and focal neurologic deficits (39%, 475/
1224) were the most commonly reported findings. Concurrent
infection (35%, 207/834) and cardiovascular disease (24%, 260/
1083) were the most common comorbidities associated with
infectious discitis. Other common comorbidities included intra-
venous drug abuse (IVDA) (15%, 226/1379), diabetes mellitus
(20%, 651/3272), immunosuppression (11%, 274/2429), and end
stage renal disease (9%, 111/1263) (Table 3).
Laboratory and diagnostic data are summarized in Table 4.
C-reactive protein (CRP) was elevated (>10 mg/L) in 85%
(1083/1272) of patients, and erythrocyte sedimentation rate
(ESR) was elevated in 69% (464/672) of patients. Leukocytosis
was found in 43% (457/1052) of patients. Magnetic resonance
imaging (MRI) and nuclear bone scan were diagnostic in 94%
(980/1045) and 93% (14/15) of patients, respectively. Com-
puted tomography (CT) was positive in in 87% (127/146) of
patients and plain radiographs in 70% (129/185) of patients.
Infection occurred in the cervical region in 12% of reported
sites (459/3824), 31% in the thoracic spine (1219/3919), and
62% in the lumbar spine (2463/3943). Blood cultures were
positive in only 51% of 930 reported cases, compared to 57%
(149/261) of percutaneous biopsies and 58% (296/511) of sur-
gical biopsies. Commonly isolated pathogens were Staphylo-
coccus aureus (38%, 1268/3360), Mycobacterium tuberculosis
(15%, 126/866), and Streptococcus species (12%, 181/1472).
Blood cultures were negative in 28% of cases (Table 4).
Treatment and Outcomes
Decompression with instrumented fusion was the most com-
monly performed intervention reported (79%, 1049/1321), com-
pared to decompression alone (22%, 223/1024) based on the
respective series reporting each variable. Combined anterior and
posterior approach was performed in 33% (448/1364) of surgical
patients, and staged surgery was performed in 26% (128/485) of
surgical patients. Repeat surgery was necessary in 13% (119/
891) of patients among the surgery-specific series (Table 5).
Follow-up was reported in 33 articles, with an average
follow-up of 26.14 months. Outcome was reported in various
ways (no pain, treatment success, etc), but functional outcome
was reported sparingly and using various metrics (return to
work, ODI, visual analog scale [VAS] score, Kirkaldy-Willis
[KW]). Four studies (all surgical) reported return-to-work out-
comes, with 88% (83/94) of patients reported as returning to
normal work activities at last follow-up. Neurologic deficits
decreased among all patients from 29% at presentation to
12% at follow-up, and from 39% among all surgical patients
to 15% at follow-up. A composite score was made to identify
all patients with a KW score of 3 or greater, ODI <20%, pain
freedom, or return to normal work status. Excellent functional
outcomes were reported in 73% (895/1234) of all patients, and
in 68% (376/555) of surgical patients. Mortality rate was 8%
among all patients, and 6% among surgical patients.
Two studies reported pain outcome of surgical and medical
management cohorts separately at last follow-up, with 85%
Figure 1. Flowchart outlining the systematic review process. The initial
PubMed search resulted in 1286 articles. Subsequent screening and
application of inclusion and exclusion criteria yielded 50 total articles to
undergo detailed review and pooling of data. Two additional articles
were identified after similar process through Cochrane Review.
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(50/59) of surgical patients reporting freedom from pain com-
pared with 52% (37/72) of medical patients (odds ratio [OR]
5.35, CI 2.27-12.60, P < .001)6,20 (Figure 2). Two articles also
reported VAS at follow-up in medical and surgical patients,
with surgical patients experiencing a significantly lower VAS
score compared with medical patients (mean difference 0.61,
CI 0.98 to 0.25).35,47 Significant study heterogeneity was
observed in both meta-analyses (Figures 2 and 3).
Table 1. Summary of the 50 Studies Included in Pooled Data for Presenting Features of Pyogenic Spondylodiscitis.
Demographics Presentation Lesion Location
First Author, Year Paper Type Patients (n) Men (n)
Mean
Age
(Years)
Time to
Diagnosis
(Days)
Back
Pain
Neurological
Findings Cervical Thoracic Lumbar
Aagaard, 2013 Retrospective review 100 37 60 32 25 26 65
Asamoto, 2005 Retrospective review 21 13 66 19 12 5 7 11
Ascione 2017 Retrospective review 30 13 64 28 30 5 0 2 20
Bernard, 2015 Randomized controlled trial 351 242 61 337 57 52 96 246
Bettini, 2009 Retrospective review 56 21 48 34 56 18 3 8 48
Butler, 2006 Retrospective review 48 24 59 47 14 4 11 30
Bydone, 2014 Retrospective review 118 57 67 61 35 40 43
Cebrian, 2012 Retrospective review 108 49 68 97 27 4 38 66
Chung, 2011 Retrospective review 20 13 60 20 14 0 8 12
Citak, 2014 Retrospective review 183 99 63 80 14 66 97
D’Agostino, 2010 Prospective series 81 51 58 55.4 79 12 10 59 12
D’Aliberti, 2012 Retrospective review 40 29 56 39 16 13 18 9
Dennis, 2017 Retrospective 84 49 62 68 19 29 79 156
Eysel, 1997 Retrospective review 55 28 52
Ha, 2007 Retrospective review 24 14 23 7 0 0 24
Hadjipavlou, 2000 Retrospective review 101 76 46 40 10 33 55
Heyde, 2006 Retrospective review 20 11 60 84 9
Homagk, 2016 Retrospective review 270 153 64 101 30 103 149
Hopf, 1998 Retrospective review 72 39 52 0 40 49
Karadimas, 2008 Retrospective review 163 101 56 13 72 88
Kaya, 2014 Retrospective review 107 64 53 97 18 7 14 90
Kehrer, 2015 Retrospective review 298 182 66 33 38 95 203
Klockner, 2003 Retrospective review 71 38 54 18 0 33 39
Krodel, 1991 Retrospective review 24 50
Legrand, 2001 Retrospective review 110 67 61 40 18 3 23 69
Lemaignen, 2017 Retrospective review 394 267 63 40 369 130 71 137 281
Lin CP, 2012 Retrospective review 48 19 67 144 48 28 0 16 38
Lin TY, 2014 Retrospective review 45 25 62 0 9 36
Lin Y, 2015 Retrospective review 22 13 55 22 8 0 0 22
Lu, 2015 Retrospective review 28 13 60 6 0 2 28
Mann, 2004 Prospective series 24 14 63 24 13 4 10 10
Nasto, 2014 Retrospective review 27 18 60 33 0 5 22
Noh, 2017 Retrospective review 31 27 68 18 3 8 20
Pee, 2008 Retrospective review 60 36 59 58 16 0 0 60
Rath, 1996 Retrospective review 43 24 60 46 35 0 19 24
Shinkel, 2003 Retrospective review 32 18 61 32 17 21 19 35
Schomacher, 2014 Retrospective review 37 24 62 37 6 6 25
Shetty, 2016 Retrospective review 27 19 48 6
Shiban, 2014 Retrospective review 113 78 104 40
Shousha, 2012 Retrospective review 30 19 65 24 12 30 0 0
Sobottke, 2009 Retrospective review 20 14 43 23 3 2 6 12
Srinivasan, 2014 Retrospective review 48 29 56
Suess, 2007 Retrospective review 24 15 65 9 24 7 3 14 7
Tsai, 2017 Retrospective review 90 61 61
Valancius, 2013 Retrospective review 196 106 52.5 177 47 9 42 125
Vcelak, 2014 Retrospective review 31 20 61 9 6 25
Viale, 2009 Prospective series 48 36 60 9 6 9 29
Wirtz, 2000 Retrospective review 59 29 61 90 46
Yaldz, 2015 Retrospective review 39 19 47 105 37 18 0 15 24
Ziu, 2014 Retrospective review 102 87 45 102 26 9 24 59
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Discussion
Spondylodiscitis is an infectious disease of the intervertebral
disc space and adjacent bone that occurs secondary to hemato-
genous seeding or direct spread from an adjacent infection
site.1 Though epidural abscess may be seen in patients with
pyogenic discitis, neurologic symptoms in the setting of
abscesses are often dealt with through prompt surgical
evacuation and not necessarily as a means of source control,
spinal stabilization, or resolution of infection, and thus must be
thought of separately from management of vertebral osteomye-
litis and discitis.55 Thus, we did not include articles primarily
discussing management of epidural abscess.
In the pathogenesis of discitis, bacteria seed the arterioles of
the vertebral end plates, resulting in pathogen deposition into
the relatively avascular intervertebral disc or adjacent vertebral
Table 2.
Surgical Treatment Follow-up
First Author, Year
Decompression or
Decompression
and Fusion Patients (n)
Duration
(Months)
Neurologic
Deficits
Return
to Work Pain Free
Oswestry
Disability
Index <20%
Excellent
Functional
Outcome
Aagaard, 2013 94 3 26
Asamoto, 2005 21 11 11
Ascione, 2017 30 30 8 22 4 22
Bernard, 2015 283 12 10
Bettini, 2009 3 56 12
Butler, 2006 0
Bydone, 2014 118 15 23
Cebrian, 2012 108 6 35 35
Chung, 2014 20 20 36 4 20 20 20
Citak, 2011 102 183
D’Agostino, 2010 10 72 65
D’Aliberti, 2012 40 40 43 13 17 17
Eysel, 1997 55 42
Ha, 2007 1
Hadjipavlou, 2000 62 47 14
Heyde, 2006 37 3
Homagk, 2016
Hopf, 1998 72 38 1
Karadimas, 2008 93 163 12 22
Kaya, 2014 94 94
Klockner, 2003 71 71 64
Krodel, 1991 36
Legrand, 2001 99 3 42 42
Lemaignen, 2017 58 378 5 26
Lin CP, 2012 48 48 64 32 32 32
Lin TY, 2014 45 45 24
Lin Y, 2015 22 22 31 0 19 19
Lu, 2015 28 28 20 0 10 15 25
Mann, 2004 24 15 15
Nasto, 2014 12 27 9
Pee, 2008 60 60 36 5
Rath, 1996 45 41 15
Shinkel, 2003 32 20 49 10
Schomacher, 2014 37 37 20
Shiban, 2014 106 3 16
Shousha, 2012 30 27 28
Sobottke, 2009 11 13
Srinivasan, 2014 48
Suess, 2007 24 24 18
Tsai, 2017 43
Valancius, 2013 117 80 12 64 64
Vcelak, 2014 31 30 12 27 27
Wirtz, 2000 59 26
Yaldz, 2015 12 39 96 1
Ziu, 2014 24 66 7
Taylor et al 53S
endplate.2,8 The poor vascularity of this region results in a
relatively safe haven for seeding bacteria and consequently
often requires prolonged antibiotic treatment.8,56 This can be
complicated by the natural history of osteomyelitis (a frequent
accompanying feature of discitis), in which bacterial growth
and purulence within vascular channels results in increased
intraosseous pressure and further worsening blood flow.57
Diagnosis of discitis begins with the clinical presentation,
whereby the vast majority of patients (91% in this series) present
with back pain. Serum studies have low specificity for disease and
may be unreliable in diagnosis.57 Still, ESR and CRP are fre-
quently elevated, and C-reactive protein levels may be useful in
determining clinical response after diagnosis is made.57 Ulti-
mately diagnosis requires advanced imaging, with MRI demon-
strating superiority in specificity compared with CT.1,57,58
Antibiotics are typically withheld until after percutaneous or sur-
gical biopsy has been performed, unless a patient demonstrates
evidence of septicemia or neurologic deficit.56 Withholding anti-
biotics is of particular importance as biopsy yield can decrease
considerably following initiation of antibiotics.56 Staphylococcus
aureus was the most common organisms isolated among pyo-
genic causes of discitis. This organism was found in 38% of the
cases in this systematic review. Of particular concern with pyo-
genic discitis is the rising prevalence of methicillin-resistant spe-
cies of Staph aureus and the implications associated with
prolonged disease due to poor bone penetrance of vancomycin.2
With treatment resistant pathogens arises the possibility of
prolonged infection and continued destruction of the vertebral
end plates and disc, which can result in progressive spinal
deformity and poor functional outcomes.1,4,56,57,59 Among his-
torical series, in which tuberculosis accounted for a substantial
portion of spondylodiscitis cases, as many as 61% of patients
developed spinal deformity.2,8 With further osseous and disco-
ligamentous destruction and deformity, kyphosis and worsened
focal spinal alignment may result in increased back pain and
overall global sagittal malalignment, which has been repeat-
edly shown to increase disability scores and reduce quality of
life.60 Among patients with deformity, and in particular seg-
mental kyphosis, surgery offers an opportunity for debride-
ment, source control, and correction of deformity.
Unfortunately, reporting of functional outcome or return-to-
work data among both medical and surgical literature is lacking.
In the current review functional outcomes were reported in only
20 studies (13 surgical) and return to work status was reported in
only 4 studies.3,13,34,41 Among the included surgical series, 88%
of patients were able to return to normal work activity. Surgical
Table 3.
Demographic and Clinical Data (n ¼ Number of Studies)
No. of patients (n ¼ 50) 4173
Percent men (n ¼ 48) 60
Age (years) (n ¼ 46) 58.28
Time to diagnosis (days) (n ¼ 16) 54.93
Length of follow-up (months) (n ¼ 33) 26.14
Comorbidities Number Total Percent
Concurrent infection (n ¼ 14) 207 834 35
Cardiovascular disease (n ¼ 13) 260 1083 24
Intravenous drug abuse (n ¼ 14) 226 1379 15
Diabetes (n ¼ 33) 651 3727 20
Immunosuppression (n ¼ 20) 274 2429 11
End-stage renal disease (n ¼ 17) 111 1263 9
Back pain on presentation (n ¼ 28) 2101 2299 91
Fever on presentation (n ¼ 21) 748 2125 35
Neurologic deficits on presentation
(n ¼ 38)
1009 3422 29
Table 4.
Laboratory and Diagnostic Data
(n ¼ Number of Studies) Number Total Percent
Imaging
MRI positive (n ¼ 14) 980 1045 94
Bone scan positive (n ¼ 1) 14 15 93
CT positive (n ¼ 4) 127 146 87
X-ray positive (n ¼ 4) 129 185 70
Levels involved
Cervical (n ¼ 40) 459 3824 12
Thoracic (n ¼ 42) 1219 3919 31
Lumbar (n ¼ 42) 2863 3943 62
Associated abscess (n ¼ 18) 567 1924 29
Labs
Elevated CRP (>10 mg/L) (n ¼ 16) 1083 1272 85
Elevated ESR (>20 mm/h) (n ¼ 12) 464 672 69
Leukocytosis (n ¼ 16) 457 1052 43
Culture yield
Surgical biopsy positive (n ¼ 13) 296 511 58
Percutaneous biopsy positive (n ¼ 8) 149 261 57
Blood culture positive (n ¼ 13) 475 930 51
Negative cultures (n ¼ 27) 447 1583 28
Culture results
Staphylococcus aureus (n ¼ 42) 1268 3360 38
Mycobacterium tuberculosis (n ¼ 23) 126 866 15
Gram-negative rods (n ¼ 28) 214 1810 12
Streptococcus (n ¼ 26) 181 1472 12
Enterococcus (n ¼ 22) 55 913 6
Abbreviations: CRP, C-reactive protein; CT, computed tomography; ESR, ery-
throcyte sedimentation rate; MRI, magnetic resonance imaging.
Table 5. Surgical Procedures Performed Among Surgical Reports.
Surgery Demographics (n ¼ Number
of Studies) Number Total Percent
Decompression and fusion among surgical
patients (n ¼ 27)
1049 1321 79
Treated surgically (n ¼ 46) 2133 3384 63
Decompression alone among surgical
patients (n ¼ 22)
223 1024 22
Anterior and posterior combined approach
(n ¼ 22)
448 1364 33
Staged surgery (n ¼ 13) 128 485 26
Reoperation rate (n ¼ 24) 119 891 13
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patients experienced excellent outcomes in 68% of those
reported at follow-up, which is comparable to all patients where
an excellent outcome was achieved in 73% of patients. Pain
outcomes and VAS scores for both surgical and medical man-
agement were investigated by 2 separate meta-analyses. While
the results from the available data suggest improved pain ratings
with surgery compared with the medical treatment alone, signif-
icant heterogeneity (I2 ¼ 56%, P ¼ .13; I2 ¼ 0%, P ¼ .43) was
detected in both studies preventing definitive determination of
the influence of surgery on pain outcomes. For both analyses,
these results can be attributed to the small sample sizes and it
must be noted that lack of control of treatment strategy (opera-
tive vs nonoperative) and surgical procedure performed further
obscures interpretation of outcome data.
The reports by Nasto et al35 and Tsai et al47 suggest a more
rapid recovery and improvement in functional scores following
surgery when compared with medical treatment alone, but with
diminishing significance over time. These results suggest that
surgery may have a role in enhancing patient’s short-term recov-
ery but may be unlikely to change long-term results as most
patients will have substantial improvement in back pain regard-
less of treatment modality. Lemaignen et al30 also demonstrated
that surgery was protective of functional outcome on univariate
analysis but not on multivariate analysis. These findings support
the need for additional research to delineate what role surgery
may have in improving functional outcomes.
This study is also limited by the availability of pooled data
from mostly retrospective studies, each with their own inherent
biases and a general lack of uniformity in reporting of out-
comes. The lack of consistent reporting of outcomes for surgi-
cal and medical series, as well as for particular surgical
procedures (instrumentation vs decompression alone), limits
our ability to perform further meta-analysis or subgroup anal-
ysis. Furthermore, the retrospective case series may suffer from
selection bias as patients who were treated surgically tended to
be those who suffered intractable back pain, neurologic deficit
or progressive spinal deformity, and thus outcome comparison
between medical and surgical treatments may be inherently
biased. Furthermore, the limitation of the search to English
may lead to reporting bias. No randomized studies were iden-
tified in this literature review comparing surgical and medical
therapies. Future prospective studies limiting comparison of
surgical and medical patients to those with similar clinical
features may reduce errors due to selection bias and provide
further insight into clinical outcomes.
Conclusions
Spondylodiscitis is a disease with increasing prevalence that
can result in poor functional outcome and progressive spinal
deformity. According to this study, most patients with spondy-
lodiscitis present with back pain. MRI and bone scan are the
most sensitive imaging modalities for detecting infectious
Figure 2. Forest plot of the odds ratios (ORs) of pain free outcomes among surgical and medical cohorts with infectious spondylodiscitis. The
estimated OR and 95% confidence interval (CI) of each included study are represented by the center of the squares and the horizontal line,
respectively. The summary OR and 95% CI are represented by the diamond. Heterogeneity and overall effect are given below the summary
statistics.
Figure 3. Forest plot of the mean difference in visual analog score among surgical and medical cohorts with infectious spondylodiscitis. The
estimated mean difference and 95% confidence interval (CI) of each included study are represented by the center of the squares and the
horizontal line, respectively. The summary mean difference and 95% CI are represented by the diamond. Heterogeneity and overall effect are
given below the summary statistics.
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spondylodiscitis, and Staph aureus is the most common organ-
ism isolated from cultures. Medical treatment is often first-line
management for infectious discitis, but surgery may be indi-
cated in cases of significant or worsening neurologic deficit,
recalcitrant infections, or progressive spinal deformity.
Functional outcomes suggest surgery may result in a greater
reduction in pain compared to medical treatment alone, but
substantial patient heterogeneity prevents definitive conclu-
sions. Further, this meta-analysis included retrospective stud-
ies, and so its conclusions should be interpreted with caution.
Direct comparison in prospective trials is needed to reduce
selection bias and definitively determine the appropriate treat-
ment algorithm.
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